Relacorilant Plus Nab-Paclitaxel Demonstrates a Progression-Free Survival Benefit in Ovarian Cancer Independent of Tumor Glucocorticoid Receptor (GR) Expression Levels

Presented: Society of Gynecologic Oncology, 12 April 2026, San Juan, Puerto Rico

Presenter: Alexander B Olawaiye, M.D.

Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.